Periodontal Conditions in Pediatric Dental Patients

Board takeaway

Separate gingival inflammation and eruption-related pseudopockets from true attachment or bone loss.

• Destructive disease in a child needs a systemic differential and timely periodontal coordination.
• Diagnose and assess risk, address home care and systemic factors, provide nonsurgical therapy, and reassess before surgery or maintenance.
• Pediatric evidence is limited; several recommendations and risk tools derive from adult studies or expert consensus.

Diagnosis and developmental context

• Review complaint, medical/dental/social histories, medications, examinations, and indicated radiographs/probing. Selective biopsy, genetic, microbiological, or biochemical testing may clarify diagnosis.
• Visually assess primary-dentition gingiva at every comprehensive and periodic examination; inspect all available radiographs for bone loss and other pathology.
• Probing may begin after first permanent molars/incisors erupt, if tolerated. Probe primary teeth earlier when clinical/radiographic findings suggest disease.
• Ages 7–17: simplified examination of four first permanent molars, maxillary right central incisor, and mandibular left central incisor.
• Record bleeding on probing (BoP), calculus, plaque-retentive factors, pocket depth (PPD), furcations, and recession.
• Newly/partially erupted teeth can have pseudopockets >3 mm. Generalized gingivitis involves ≥30% of teeth; visual assessment is useful when probing is not feasible.
• Even limited BoP in early primary dentition signals susceptibility. Bone loss and premature primary-tooth loss are warning findings.
• Primary crest-to-CEJ distance: normally 1 ±0.5 mm; >2 mm suggests loss, with possible physiologic exceptions beside exfoliating/erupting teeth. Permanent dentition: approximately 2 mm, range 1–3 mm.
• Use quality bitewings for bone assessment; periapicals help investigate anterior mobility or associated pathology such as root resorption.

Classification, risk, and prognosis

Classify disease

• Current disease categories: periodontitis, necrotizing periodontitis, and periodontitis associated with systemic conditions. Former “chronic” and “aggressive” categories are grouped under periodontitis.
• Stage describes severity/complexity; grade describes progression risk and anticipated response. Add localized (< 30% of teeth), generalized, or molar/incisor distribution.
• Stage I: interdental clinical attachment loss (CAL) of 1–2 mm; maximum PPD ≤4 mm.
• Stage II: CAL of 3–4 mm; maximum PPD ≤5 mm.
• Stages III–IV: CAL ≥5 mm.
  • Stage III includes periodontitis-related loss of ≤4 teeth, ≥6-mm pockets, and class II/III furcations.
  • Stage IV includes loss of ≥5 teeth and greater rehabilitation complexity, such as dysfunction, major mobility, and bite collapse.

Grade can use direct longitudinal loss or indirect evidence when serial records are unavailable.

• In the indirect calculation, enter radiographic bone loss as a percentage of root length, then divide by age in years; document the estimate and its basis.
• Destruction disproportionate to biofilm and an early-onset molar/incisor pattern are additional Grade C clues, not proof from age or distribution alone.

Smoking and diabetes modify grade; the source table uses HbA1c 7% and smoking 10 cigarettes/day as B/C boundaries. An HbA1c boundary used for grading is not a dental-treatment clearance threshold.

Estimate patient risk

• Assess risk initially and periodically. Strong risks include systemic/genetic susceptibility, tobacco exposure, disproportionate inflammation, subgingival calculus, abnormal mobility, furcations, and periodontitis-related tooth loss.
• Under 13: any BoP, PPD >3 mm, or radiographic bone loss is a high-risk factor; interpret eruption context. Generalized gingivitis is a moderate-risk factor in the PDF table.

Adolescent thresholds

• Age ≥13: use the following risk factors. Bone loss at >25% of sites is also a high-risk factor.

• Include nutrition, medications, immunosuppression/radiation, trauma, hygiene barriers, access/health literacy, and caregiver support. Adolescents add pregnancy, mental health, drug misuse, piercings, and supported-home care considerations.
• Clinical judgment determines overall risk; this is not a validated pediatric point score.
• Revisit favorable/questionable/unfavorable/hopeless prognosis throughout treatment; plan immediate pain/infection care, intermediate therapy, and long-term maintenance with family priorities.

Behavior and nonsurgical therapy

• Use motivational approaches; teach individualized brushing twice daily and flossing daily, caregiver assistance, adjuncts, healthy nutrition, injury prevention, and tobacco/drug cessation referral.
• Prophylaxis removes supragingival deposits; debridement removes subgingival biofilm; scaling removes deposits/stains; root planing addresses contaminated/rough root surfaces.
• Hand and ultrasonic instrumentation have similar overall treatment outcomes; choose by access, anatomy, tolerance, and operator/patient preference.
• Consider chemical antiplaque adjuncts and closer recalls for adolescents or patients with special health care needs and poor hygiene. Mouthrinses and ultrasonics may be contraindicated when inability to expectorate creates aspiration risk.
• Correct overhangs/defective restorations; contour and fit preformed crowns well. Consider restoring arrested open cavities when food impaction causes inflammation, bleeding, or discomfort.
• Increase orthodontic recall/prophylaxis when needed; consider pausing treatment if adequate hygiene cannot be maintained.
• Address defect-related sensitivity with appropriate desensitizing toothpaste, varnish, soft brushes, or enamel sealants to facilitate hygiene.

Antibiotic adjuncts and reassessment

• Antibiotics do not replace scaling and root planing (SRP). Consider adjuncts for advanced/rapidly destructive disease; necrotizing and systemic-associated periodontitis may benefit.
• Source narrative also identifies moderate disease with CAL 3–4 mm and PPD < 5 mm as an indication; its formal recommendation emphasizes individualized selection for advanced/aggressive disease.
• Do not treat the threshold as an automatic prescription.
• Weigh general health, severity, allergy, adherence, resistance, adverse effects, and response to SRP. Local antibiotics have small benefits and cost concerns; often used for isolated residual/recurrent pockets.
• Source discusses amoxicillin/metronidazole, metronidazole alone for penicillin allergy, and azithromycin-based approaches.
• Azithromycin requires caution with cardiac/QT risk; periodontal regimens differ from odontogenic-infection or endocarditis-prophylaxis regimens.
• No dosing is supplied here.
• Healing after phase I may take ≥4 weeks. Reassess probing, anatomy, residual disease, hygiene, and harmful habits before deciding on further nonsurgical or surgical care.

Systemic and medication considerations

• Investigate diabetes, immune/connective-tissue/metabolic/endocrine disorders and medication effects; coordinate with medical providers.
• Halitosis: establish cause, including tongue coating, periodontal infection, reduced saliva, or nasal/GI conditions. Tongue cleaning and indicated plaque/antimicrobial treatment address causes; odor masking alone does not.
• Respiratory disease/mouth breathing and medication-related dryness can impair oral health. Review medications, reinforce fluoridated toothpaste and rinsing after medication, and refer to ENT when obstruction affects periodontal health.
• Immunosuppression/radiation: coordinate timely safe care before, during, and after therapy.
• Watch bleeding, necrosis, dryness, opportunistic infection, graft-versus-host disease, and partially erupted molar pericoronitis.
• Assess/treat periodontium before cancer-related bisphosphonates; hopeless teeth may require extraction when definitive therapy is unavailable.
• Drug-related enlargement: anticonvulsants, calcium-channel blockers, and immunosuppressants contribute fibrotic enlargement with superimposed plaque inflammation.
• Consider medication change through medical coordination; start biofilm control/SRP and reassess before surgery.
• For enlargement, gingivectomy generally fits ≤6 teeth without CAL/osseous needs; flap surgery fits larger areas with CAL or osseous needs.

Trauma, infection, and self-injury

• Soft-tissue trauma: inspect for foreign bodies; use soft-tissue radiographs when indicated. Remove debris, cleanse/debride, obtain hemostasis, and close while preserving vascularity.
• Check tetanus status; uncertain immunization warrants physician evaluation within 48 hours. Antibiotic prophylaxis depends on contamination/severity; systemic prophylaxis is recommended after tooth replantation.
• Dental splints should be passive, flexible, nonirritating, and permit hygiene/physiologic mobility. Alveolar fractures need greater rigidity and longer splinting.
• Monitor resorption, ankylosis, marginal bone loss, and tooth loss. Replantation after >60 minutes dry time carries substantial ankylosis/replacement-resorption concern; milk or Hanks’ Balanced Salt Solution supports PDL-cell preservation.
• Nonplaque bacterial, fungal, or viral lesions may persist despite plaque removal: control pain/fever, maintain hydration, reduce contributing risks, and consider antimicrobial therapy for non-self-limiting or frequently recurrent infection.
• Traumatic mucosal lesions: identify/remove physical, chemical, or thermal cause and provide symptom relief.
• Self-injury needs individualized medical/behavioral assessment, protective approaches, and ongoing monitoring; permanent defects may need grafting.

Pericoronitis and airway danger

• Acute care: irrigate/debride, drain purulence, assess opposing-tooth trauma, use NSAID pain control, and prescribe antibiotics when infection spreads beyond a localized site or has systemic signs.
• Home care: cleaning, warm saline rinses, appropriate antiseptic agents, and fluids. After symptoms resolve, assess eruption prognosis and recurrence risk; consider flap removal or extraction.
• Suspected Ludwig’s angina requires immediate intervention and emergency ENT/oral-surgery referral without delay because airway compromise can progress rapidly.

Decision map: pericoronitis escalation

Loading diagram…

Localized pericoronitis alone does not automatically require systemic antibiotics. Spreading infection or systemic signs changes that decision; airway danger changes the setting and urgency. Definitive management follows reassessment after symptom control.

Referral and surgical decisions

• Consider periodontist referral for PPD >5 mm, extensive CAL in a young child, rapid destruction, persistent inflammation after adequate SRP, systemic compromise, furcation/access difficulty, hypermobility, short roots, or risk to permanent successors.
• Coordinate medical and periodontal treatment. If persistent infection threatens life or developing teeth, jointly weigh conservative care against extraction; arrange pediatric behavior/pain support and timely communication around visits.
• Surgery follows inadequate nonsurgical control or defects requiring correction; explain risks, benefits, alternatives, and obtain written informed consent. Refer beyond scope.

Choose the surgical approach

• Gingivectomy improves access/contour for selected enlargement or firm suprabony pockets; avoid with increased bleeding risk, required bone access, narrow keratinized tissue, or esthetic concerns.
• Flaps provide access for SRP, resection, and regeneration, with anterior esthetic tradeoffs.
• Regeneration can improve intrabony-defect CAL/PPD versus flaps alone, but demands technique and maintenance adherence. Laser use risks thermal necrosis; evidence for adjunctive resective/regenerative benefits remains insufficient.
• Extraction may follow failed therapy or an unfavorable overall risk/benefit balance; primary lesions near successors may endanger development.
• Esthetic crown lengthening for altered passive eruption is best after facial growth; assess other causes of excessive display. Selected orthodontic patients may merit soft-tissue grafting for worsening mucogingival risk.

Replacement during growth

• Favor conservative replacement during growth.
• Source generally discourages implants before age 18 in women/21 in men, but skeletal maturation—not birthday alone—guides timing.
• Early implants risk infraocclusion/rotation; temporary extra-narrow implants after age 15 have limited supporting studies.

Maintenance

• Individualize supportive therapy by initial severity, residual sites, response, symptoms, imaging, hygiene, age, systemic risks, and caries risk. Reinforce home care and decide when to re-enter phase I/II.
• Higher-risk supportive therapy: every 2–4 months. Lower-risk supportive therapy: at least every 12 months.
• The source gives the following example pathways; interpret them with individual findings.

Common board traps

Answer aloud

A young child has early molar loss and posterior bone loss. What next?

Establish whether the tooth loss and bone change are pathological rather than related to normal exfoliation or eruption.

• Assess attachment, mobility, indicated imaging, medical and family history, and systemic or genetic clues.
• Coordinate pediatric and periodontal evaluation for destructive disease.
• Preserve teeth when feasible, but reassess prognosis if persistent infection threatens the child or developing successors; extraction is an individualized multidisciplinary decision.

Inflammation persists after SRP. How do you escalate?

Reassess after adequate healing—phase I healing may take at least four weeks—and check residual deposits, home care, local retention factors, probing findings, and systemic contributors.

• Reinforce or repeat nonsurgical therapy as indicated.
• Selected rapidly destructive or advanced disease may benefit from antibiotic adjuncts to scaling and root planing; persistent deep pockets or complex defects warrant periodontal referral and possible surgery.
• Establish maintenance based on residual disease and risk.

A partially erupted molar causes fever and spreading swelling. What changes?

Treat this as spreading/systemic infection: assess airway safety immediately, provide local source control and indicated antibiotics, and escalate when needed.

• Fever and spreading swelling exceed simple localized pericoronitis.

• Assess systemic and airway risk, provide local debridement or drainage and indicated antibiotics, and address pain and hydration.

• A threatened airway requires urgent referral or escalation.

• After the acute problem is controlled, plan definitive care to prevent recurrence.

Does a deep pocket around an erupting permanent molar establish periodontitis?

No. Distinguish an eruption pseudopocket from true clinical attachment or bone loss.

• Interpret depth with eruption, bleeding, attachment level, mobility, and indicated imaging.
• Probe when tolerated after permanent molar/incisor eruption; investigate primary teeth earlier if disease is suspected.
• Bone loss or premature primary-tooth loss requires evaluation rather than dismissal as normal development.

Are antibiotics the primary treatment for pediatric periodontitis?

No. They are selected adjuncts to mechanical therapy, not substitutes for scaling and root planing.

• Consider advanced/rapidly destructive, necrotizing, or systemic-associated disease and treatment response.
• Weigh general health, allergies, adherence, adverse effects, and resistance; coordinate periodontal/medical care.
• A pocket-depth or attachment-loss threshold alone is not an automatic prescription.